Suvorexant Inversely Affects Phosphorylated Tau in Human Cerebrospinal Fluid and Plasma
Alzheimer disease (AD) is characterized by amyloid-{beta} plaques and neurofibrillary tangles of tau. Suvorexant, a dual orexin receptor antagonist, was pr
Alzheimer disease (AD) is characterized by amyloid-{beta} plaques and neurofibrillary tangles of tau. Suvorexant, a dual orexin receptor antagonist, was pr